focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Auditor

4 Oct 2022 15:30

RNS Number : 7583B
Maven Income & Growth VCT PLC
04 October 2022
 

MAVEN INCOME AND GROWTH VCT PLC (Maven VCT), MAVEN INCOME AND GROWTH VCT 3 PLC (Maven VCT 3), MAVEN INCOME AND GROWTH VCT 4 PLC (Maven VCT 4), and MAVEN INCOME AND GROWTH VCT 5 PLC (Maven VCT 5); (each a Company and together the Companies) 

Change of Auditor

Following a formal tender process, the Companies are pleased to announce the appointment of Johnston Carmichael LLP (Johnston Carmichael) as its new Auditor with effect from 4 October 2022. Johnston Carmichael will conduct the audit of each Company's financial statements for their current financial years, which are to 30 November 2022 for Maven VCT 3 and Maven VCT 5; 31 December 2022 for Maven VCT 4; and 28 February 2023 for Maven VCT. The appointment of Johnston Carmichael as Auditor for each Company's subsequent financial year will be subject to approval by Shareholders at their next respective Annual General Meetings, all to be held in 2023.

In accordance with Section 519 of the Companies Act 2006, the Company's previous Auditor, Deloitte LLP (Deloitte), has deposited a statement with each of the Companies of the circumstances connected with them ceasing to hold office as Auditor of the Companies (the Statement). Each Statement confirms that Deloitte resigned as Auditor of the relevant Company because they considered that the fee was uneconomic, given the effort required to conduct the audit. Copies of the Statements will be sent to every person who is entitled to receive a copy of each Company's Annual Reports and Financial Statements.

The Boards of the Companies wish to take this opportunity to extend their appreciation and gratitude to Deloitte for the services rendered to the Companies during its respective periods of tenure.

Issued on behalf of the Companies

Maven Capital Partners UK LLP, Secretary

4 October 2022

Enquiries: 

Graeme Cullen, Maven Capital Partners UK LLP:

Tel: +44 (0) 141 206 0110

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPGBPUUPPGCC
Date   Source Headline
1st Oct 201912:34 pmRNSNet Asset Value(s)
20th Sep 201912:44 pmRNSHalf-year Report
19th Sep 20193:46 pmRNSTransaction in Own Shares
17th Sep 20193:00 pmRNSTransaction in Own Shares
28th Aug 20192:59 pmRNSStatement re Possible Merger
27th Aug 20194:38 pmRNSStatement re NAV and Interim Dividend
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription
21st Aug 20194:14 pmRNSStatement re share premium account cancellation
21st May 20194:04 pmRNSTransaction in Own Shares
15th May 20195:02 pmRNSNet Asset Value(s)
15th May 20192:08 pmRNSResult of AGM
5th Apr 20193:25 pmRNSAnnual Financial Report
12th Mar 20192:52 pmRNSTransaction in Own Shares
28th Feb 20194:03 pmRNSNet Asset Value(s)
4th Dec 20184:42 pmRNSTransaction in Own Shares
27th Nov 20183:15 pmRNSTransaction in Own Shares
22nd Nov 20183:14 pmRNSTransaction in Own Shares
19th Nov 201811:45 amRNSDirector/PDMR Shareholding
19th Nov 201811:43 amRNSDirector/PDMR Shareholding
19th Nov 201811:40 amRNSDirector/PDMR Shareholding
15th Nov 20183:36 pmRNSDirectorate Change
15th Nov 20183:01 pmRNSMerger Update: Approval of Scheme
8th Nov 20184:27 pmRNSNet Asset Value(s)
1st Nov 201812:31 pmRNSResult of General Meeting
8th Oct 20187:00 amRNSStatement re Proposed Merger
14th Sep 20183:37 pmRNSHalf-year Report
13th Sep 20186:16 pmRNSPossible Merger
31st Aug 20184:04 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:47 pmRNSStatement re DIS
18th May 20184:47 pmRNSNet Asset Value(s)
17th May 20184:30 pmRNSDividend Declaration
15th May 20181:49 pmRNSResult of AGM
24th Apr 20184:52 pmRNSIssue of Equity
13th Apr 201812:48 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
6th Apr 20184:41 pmRNSStatement re Dividend Investment Scheme
6th Apr 20184:34 pmRNSAnnual Financial Report
6th Apr 20189:23 amRNSDirector/PDMR Shareholding
6th Apr 20189:22 amRNSDirector/PDMR Shareholding
5th Apr 20186:23 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
8th Mar 20183:30 pmRNSDividend Declaration
6th Mar 20185:24 pmRNSTransaction in Own Shares
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
26th Feb 20184:25 pmRNSNet Asset Value(s)
6th Feb 20185:19 pmRNSDirector/PDMR Shareholding
6th Feb 20185:18 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:46 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.